TITLE

Antiglycine receptor-related stiff limb syndrome in a patient with chronic lymphocytic leukaemia

AUTHOR(S)
Derksen, Angelika; Stettner, Mark; Stöcker, Winfried; Seitz, Rüdiger J.
PUB. DATE
May 2013
SOURCE
BMJ Case Reports;May2013, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
88013041

 

Related Articles

  • Cyclophosphamide/fludarabine/rituximab.  // Reactions Weekly;8/1/2013, Issue 1463, p17 

    The article presents case studies of female patients, aged 69 and 47 years with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab (FCR), who developed myelodysplastic syndrome due to prolonged myelosuppression.

  • Chronic Leukemia.  // Current Medical Literature: Leukemia & Lymphoma;2014, Vol. 22 Issue 1, p24 

    The article presents abstracts on chronic leukemia including the genetic pathways leading to the transformation of chronic lymphocytic leukemia, ibrutinib therapy for lymphocytic leukaemia elderly patients and one on chronic lymphocytic leukemia (CLL).

  • Alemtuzumab.  // Reactions Weekly;Apr2015, Vol. 1547 Issue 1, p19 

    The article presents case studies of patients with chronic lymphocytic leukaemia, who developed virus reactivations during alemtuzumab treatment.

  • Obinutuzumab + chlorambucil a cost-effective strategy in CLL.  // PharmacoEconomics & Outcomes News;Feb2015, Vol. 722 Issue 1, p21 

    The article reports on the cost effectiveness of combined obinutuzumab and chlorambucil therapy in treating patients suffering from chronic lymphocytic leukaemia (CLL).

  • Cyclophosphamide/fludarabine/rituximab.  // Reactions Weekly;Feb2015, Vol. 1539 Issue 1, p113 

    The article describes the case of febrile neutropenia that developed in a female patient following treatment with cyclophosphamide, fludarabine and rituximab for chronic lymphocytic leukaemia.

  • Antineoplastics.  // Reactions Weekly;6/22/2013, Issue 1458, p8 

    The article describes the case of a 75-year-old man who developed myelodysplastic syndrome and pure erythroid leukaemia while receiving treatment with cladribine, cyclophosphamide, vincristine, prednisone and fludarabine for chronic lymphocytic leukaemia (CLL).

  • The stiff limb syndrome — a new case and a literature review. Bartsch, T.; Herzog, J.; Baron, R.; Deuschl, G. // Journal of Neurology;Apr2003, Vol. 250 Issue 4, p488 

    Presents a letter to the editor about stiff limb syndrome.

  • cladribine.  // Royal Society of Medicine: Medicines;2002, p157 

    The article presents information on cladribine, an antimetabolite cytotoxic which is used as an anticancer treatment for hairy cell leukaemia, also chronic lymphocytic leukaemia in certain patients. Administration is by injection.

  • Antineoplastics.  // Reactions Weekly;9/8/2012, Issue 1418, p11 

    The article describes the case of a female patient who developed paraneoplastic pemphigus while being treated with fludarabine and cyclophosphamide (FC) for chronic lymphocytic leukaemia (CLL).

  • Cladribine/rituximab.  // Reactions Weekly;Jan2015, Vol. 1533 Issue 1, p132 

    An abstract of the article "Rituximab and subcutaneous cladribine: Clinical results of an extended cohort of chronic lymphocytic leukaemia patients," by P. Bertazzoni and colleagues is presented.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics